An ARUP expert will answer questions about a proposed FDA rule to regulate laboratory-developed tests (LDTs) as medical devices, which will potentially limit patient access to essential medical care.
Webinar: November 29, 2023, 11 AM–NOON (MST)ARUP experts seek to increase understanding of the FDA’s proposed rule to regulate lab-developed tests as medical devices and the impact on hospitals and patients during a webinar on November 29.
ARUP has gained a Conformité Européenne (CE) mark for AAV5 DetectCDx™ single-site use. The test will aid in determining the eligibility of non-U.S. patients for a new hemophilia A gene therapy.
A panel discussion at the Utah Life Sciences Summit explored how the FDA’s proposed rule to further regulate laboratory-developed tests could slow advances in diagnostic medicine.
Our experts are passionate about improving diagnostic testing. More than 100 nationally and internationally recognized pathologists, subspecialty-qualified clinicians, board-certified clinical scientists, clinical variant scientists, and genetic counselors are available for consultation, interpretation, and collaboration with clients.
Medical Experts 
Genetic CounselorsAt ARUP, our employees feel purposeful. Our culture of acceptance and collaboration provides multiple opportunities to learn, grow, and mentor. This, and more, is why ARUP has won the Utah Business Best Companies to Work For award multiple times.
We are an integral part of diagnostic medicine—a vital part of a patient’s healthcare journey—and we have a job for you!
Connect Sign In
